Cevimeline-d4 Hydrochloride Salt (Major)

CAS : 107220-28-0

Ref. TR-C283502

Informations sur le produit

• Nom: Cevimeline-d4 Hydrochloride Salt (Major)
• Synonymes: (+/-)-cis-2-Methylspiro[1,3-oxathiolane-5,3’-quinuclidine-d4 Hydrochloride, AF-102B-d4 Hydrochloride, SNI-2011-d4 Hydrochloride, Evoxac-d4 Hydrochloride, Af 102B, Cevimeline hydrochloride, Evoxac, Fks 508, Saligren, Snd 5008, Sni 2011, Snk 508, Spiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)oxathiolane), 2'-methyl-, hydrochloride, cis-, Spiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)oxathiolane), 2'-methyl-, hydrochloride, trans-, Spiro[1-azabicyclo[2.2.2]octane-3,5′-[1,3]oxathiolane], 2′-methyl-, hydrochloride (1:1), (2′R,3R)-rel-, Spiro[1-azabicyclo[2.2.2]octane-3,5′-[1,3]oxathiolane], 2′-methyl-, hydrochloride, (2′R,3R)-rel-, cis-(+-)-2'-Methylspiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)oxathiolane) hydrochloride, cis-2-Methylspiro[1,3-oxathiolane-5,3′-quinuclidine] hydrochloride, trans-2'-Methylspiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)oxathiolane) hydrochloride

Description

Applications A labelled muscarinic M1 and M3 receptor agonist. Sialagogue.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Masunaga, H., et al.: Eur. J. Pharmacol., 339, 1 (1997), Arisawa, H., et al.: Arzneim.-Forsch., 52, 14 (2002), Yasuda, H., et al.: Clin. Drug Invest., 22, 67 (2002), Ono, M., et al.: Am. J. Ophthalmol., 138, 6 (2004),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 239.8
• Formule: C₁₀H₁₄D₄ClNOS
• Couleur/Forme: Neat
• InChI: InChI=1S/C10H17NOS.ClH/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11;/h8-9H,2-7H2,1H3;1H/t8-,10-;/m0./s1/i1D3,8D
• Code InChI: InChIKey=SURWTGAXEIEOGY-LQLIPKPHSA-N
• SMILES: Cl.[2H]C([2H])([2H])[C@@]1([2H])O[C@]2(CS1)C[N@]1CC[C@H]2CC1